meningitis%20-%20acute,%20bacterial%20(pediatric)
MENINGITIS - ACUTE, BACTERIAL (PEDIATRIC)
Acute meningitis is the bacterial infection of the subarachnoid space and cerebrospinal fluid that may cause local and systemic inflammatory response.
Common symptoms in newborns are lethargy, fever, seizures, irritability and bulging fontanelle. While in children the common symptoms are fever, nuchal rigidity (incidence increases with age) and altered consciousness.
Meningeal signs are stiff neck, Kernig's or Brudzinski's signs) are not reliably present in infants <6 months of age.
It may also observe the presence of persistent vomiting, changes in behavior or other psychological/neurologic signs.

Definition

  • Bacterial infection of the meninges & subarachnoid space

Etiology

Other causes of acute meningitis include the following:

  • Spirochetes (eg Treponema pallidum)
  • Mycobacteria (eg Mycobacterium tuberculosis)
  • Fungi (eg Cryptococcus, Coccidioides, Sporothrix)
  • Viruses [eg herpes simplex virus (HSV), varicella zoster, cytomegalovirus (CMV)]
  • Protozoa & helminths

Signs and Symptoms

  • Symptoms are variable in children, especially in the early stage of the illness
  • Common symptoms may be observed according to age group
    • Newborns: Lethargy, fever, seizures, irritability, bulging fontanelle, poor feeding
    • Children: Fever, nuchal rigidity (incidence increases w/ age), altered consciousness, seizures
  • Meningeal signs (stiff neck, Kernig’s or Brudzinski’s sign) are not reliably present in infants <6 months of age
  • May also observe persistent vomiting, changes in behavior or other psychological/neurologic signs
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 4 days ago
Every-two-month injections of the long-acting cabotegravir + rilpivirine were noninferior to once-monthly injections for virologic suppression at 48 weeks in people living with HIV*, according to the ATLAS-2M** study presented at CROI 2020 — thus providing a potential option with more convenient dosing.
Stephen Padilla, 19 Mar 2020
The assumption that children are less vulnerable to the coronavirus disease 2019 (COVID-19) compared to adults is not quite true and may even be dangerous, suggests a recent study.
22 Mar 2020
Sustained use of lopinavir-combined regimen appears to confer benefits among patients with the novel coronavirus disease (COVID-19), with improvement possibly indicated by increasing eosinophils, suggests a recent study.
24 Mar 2020
COVID-19 is a novel disease, with no existing immunity. The virus can be transmitted from person to person, quickly and exponentially. Here’s what we can do to slow down the spread, if not contain the outbreak.